A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis
2005 ◽
Vol 64
(1)
◽
pp. 64-69
◽
2013 ◽
Vol 71
(Suppl 3)
◽
pp. 194.3-195
P. Durez
◽
M. Genovese
◽
H. Kellner
◽
C. Codding
◽
G. Ligozio
◽
...
2015 ◽
Vol 67
(7)
◽
pp. 1703-1710
◽
Mark C. Genovese
◽
Katerina Jarosova
◽
Dorota Cieślak
◽
Jeffrey Alper
◽
Alan Kivitz
◽
...
Richard F. Riedel
◽
Karla V. Ballman
◽
Yao Lu
◽
Steven Attia
◽
Elizabeth T. Loggers
◽
...
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 717.1-717
T. Takeuchi
◽
C. Thorne
◽
G. Karpouzas
◽
S. Sheng
◽
W. Xu
◽
...
2019 ◽
Vol 68
(4)
◽
pp. 261-274
◽
David L. Boyle
◽
Samuel E. DePrimo
◽
Cesar Calderon
◽
Dion Chen
◽
Paul J. Dunford
◽
...
2016 ◽
Vol 27
◽
pp. vi180
S. Yuki
◽
Y. Komatsu
◽
H. Satake
◽
Y. Miyamoto
◽
H. Tanioka
◽
...
2016 ◽
Vol 80
(3)
◽
pp. 668-676
◽
Hiroyuki Tsutsui
◽
Shinichi Momomura
◽
Akira Yamashina
◽
Hisao Ogawa
◽
Hiroaki Shimokawa
◽
...
Close
Export Citation Format
Close
Share Document
Close